top of page

BioVenture VoiCes Episode 42: Nextech's Thilo Schroeder

  • Jun 15
  • 1 min read

An early investor in recent mega successes such as Revolution Medicines, Peloton, Blueprint Medicines, and Parabilis, he describes his investment philosophy and focus on precision oncology companies. Plus, his early life, getting hands on experience in biotech at Micromet, and learning from some of the top investors and scientific advisors in the industry.




Chapters

Early life and university - 0:58

Micromet - 11:18

PhD & SiROP - 13:50

Joining Nextech - 19:48

"Character forming years" - 27:31

Keeping a focus in oncology - 36:36

Investing at the PoC stage - 44:00

Investment themes - 52:49

The business side - 56:58

Personal life - 102:57

Join the BiotechTV mailing list

Thanks for subscribing!

Follow BiotechTV

  • Twitter

@BiotechTV

  • LinkedIn

BiotechTV

  • Facebook

BiotechTVHQ

  • TikTok

@BiotechTV

  • Instagram

@BiotechTVHQ

Also look for unique social pages for BiotechTV U.

Sponsor Spotlight

10x_Genomics_logo.svg.png

10x Genomics delivers powerful, reliable tools that fuel scientific discoveries and drive exponential progress to master biology to advance human health. Cited in more than 10,000 research papers, our innovative single cell, spatial, and in situ technologies enable discoveries across oncology, immunology, neuroscience, and more.

 

Our talented, dedicated science professionals have a distinguished record of creating innovative instruments, reagents, and software that analyze biological systems at a resolution that matches the complexity of biology.

Learn more

bottom of page